Hospital
ST. Vincent Anderson Regional Hospital, INC.
ST. Vincent Anderson Regional Hospital, INC. was paid $23.64M by Medicaid between Jan 2018 and Dec 2024, across 135 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.
33Billing provider infoST. VINCENT ANDERSON REGIONAL HOSPITAL, INC.
ANDERSON, IN 46016
ANDERSON, IN 46016
33aNPI1679578850assigned 06/15/2005
33bProvider typePsychiatric Hospital Unit
28Total paid$23.64M
24GClaims459,428
24DCodes billed135
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in Indiana
Rank by total paid#4 of 5
Median peer was paid$25.59M
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 70,615 | $1.38M | |
| 2019 | 55,537 | $2.00M | |
| 2020 | 64,017 | $3.04M | |
| 2021 | 78,483 | $4.42M | |
| 2022 | 72,823 | $4.54M | |
| 2023 | 67,217 | $4.71M | |
| 2024incomplete | 50,736 | $3.55M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 29,595 | 26,599 | $3.92M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 27,228 | 22,711 | $2.75M |
| 41899 | Unlisted procedure, dentoalveolar structures | 9.1% | 1,369 | 1,250 | $2.15M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 7.0% | 18,427 | 11,648 | $1.66M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.0% | 17,761 | 15,220 | $1.65M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 5.5% | 20,138 | 15,591 | $1.31M |
| 71045 | Radiologic examination, chest; single view | 5.5% | 11,780 | 9,817 | $1.29M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.3% | 17,435 | 14,458 | $1.02M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.9% | 1,769 | 1,466 | $688K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.9% | 14,411 | 11,739 | $682K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.8% | 6,958 | 6,528 | $659K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.6% | 1,887 | 1,573 | $610K |
123 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | 1.9% | 3,938 | $458K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.8% | 10,711 | $429K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.8% | 4,339 | $425K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.5% | 3,549 | $355K |
| 80053 | Comprehensive metabolic panel | 1.1% | 49,998 | $258K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.0% | 2,529 | $241K |
| 90837 | Psychotherapy session, about an hour | <1% | 2,743 | $232K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 59,430 | $226K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,232 | $221K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 4,402 | $176K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,838 | $175K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 4,223 | $160K |
| 77386 | <1% | 285 | $150K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 962 | $149K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,992 | $113K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 716 | $105K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,307 | $102K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 645 | $92K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 972 | $92K |
| 80306 | <1% | 8,458 | $84K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,114 | $81K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 832 | $79K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 705 | $72K |
| 84484 | <1% | 10,316 | $70K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 866 | $57K |
| 36415 | Collection of venous blood by venipuncture | <1% | 24,727 | $43K |
| 66821 | <1% | 79 | $41K | |
| 76830 | Ultrasound, transvaginal | <1% | 234 | $41K |
| 83880 | <1% | 1,761 | $33K | |
| 81025 | <1% | 5,799 | $30K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,051 | $30K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,192 | $29K |
| 83690 | <1% | 9,282 | $27K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 174 | $26K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 134 | $23K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 35 | $23K |
| 81001 | <1% | 13,295 | $21K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 108 | $20K |
| 80061 | Lipid panel | <1% | 2,141 | $19K |
| 87088 | <1% | 4,339 | $18K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 104 | $16K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 49 | $16K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 146 | $13K |
| 83735 | <1% | 3,983 | $12K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 80 | $12K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 829 | $11K |
| 77336 | <1% | 114 | $11K | |
| 88342 | <1% | 94 | $11K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 234 | $10K |
| 87634 | <1% | 233 | $10K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,051 | $9K |
| 86140 | <1% | 3,273 | $7K | |
| 82728 | <1% | 1,110 | $7K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 57 | $6K |
| 83605 | <1% | 902 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 893 | $6K |
| 85730 | <1% | 1,500 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 44 | $4K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 44 | $4K |
| 85610 | <1% | 1,916 | $4K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 120 | $4K |
| 83550 | <1% | 811 | $3K | |
| 85652 | <1% | 2,721 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 227 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 161 | $3K |
| 83540 | <1% | 843 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 221 | $2K |
| 86592 | <1% | 615 | $2K | |
| 92557 | <1% | 14 | $1K | |
| 81003 | <1% | 1,153 | $1K | |
| 87081 | <1% | 174 | $1K | |
| 82607 | <1% | 184 | $1K | |
| 84439 | <1% | 204 | $1K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 13 | $1K |
| 82746 | <1% | 150 | $970.05 | |
| 85379 | <1% | 210 | $969.38 | |
| 80076 | <1% | 204 | $890.05 | |
| 86803 | <1% | 89 | $830.04 | |
| 86850 | <1% | 251 | $780.11 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 15 | $747.30 |
| 85027 | <1% | 205 | $615.45 | |
| 86762 | <1% | 89 | $561.02 | |
| 82805 | <1% | 13 | $551.39 | |
| 87430 | <1% | 80 | $459.56 | |
| 80143 | <1% | 47 | $447.36 | |
| 83021 | <1% | 40 | $404.58 | |
| 80179 | <1% | 32 | $298.24 | |
| 87340 | <1% | 71 | $279.77 | |
| 87807 | <1% | 20 | $220.04 | |
| 82553 | <1% | 51 | $212.88 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 19 | $208.02 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 19 | $208.02 |
| 87077 | <1% | 47 | $196.97 | |
| 82550 | <1% | 51 | $190.60 | |
| 84702 | <1% | 26 | $177.50 | |
| 84703 | <1% | 34 | $142.14 | |
| 82948 | <1% | 47 | $140.64 | |
| 86901 | <1% | 96 | $135.56 | |
| 86900 | <1% | 97 | $131.76 | |
| 83516 | <1% | 17 | $126.83 | |
| 82043 | <1% | 28 | $116.35 | |
| 82950 | <1% | 31 | $110.92 | |
| 82570 | <1% | 28 | $104.18 | |
| 87040 | <1% | 13 | $103.20 | |
| 80047 | <1% | 88 | $101.16 | |
| 82784 | <1% | 17 | $93.00 | |
| 82150 | <1% | 13 | $63.66 | |
| 87186 | <1% | 13 | $58.73 | |
| 85018 | <1% | 81 | $34.08 | |
| 85014 | <1% | 81 | $34.08 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,767 | $26.10 |
| 82962 | <1% | 13 | $6.18 | |
| J2704 | Injection, propofol, 10 mg | 0% | 241 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 87 | $0.00 |
| A9270 | Non-covered item or service | 0% | 435 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 95 | $0.00 |
| 92567 | 0% | 13 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 112 | $0.00 |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 0% | 12 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 26 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 136 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 611 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 139 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJACOBSON, BECKY (VICE PRESIDENT OF FINANCE)
| Provider | Location | Paid |
|---|---|---|
| ST Vincent Fishers Hospital INC | Fishers, IN | $415K |
| ST. Vincent Anderson Regional Hospital, INC. | Anderson, IN | $104K |
| ST. Vincent Anderson Regional Hospital, INC. | Anderson, IN | $56K |
| ST. Vincent Anderson Regional Hospital, INC. | Anderson, IN | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.